Body, J., Moos, R. v., Niepel, D., & Tombal, B. (2018, September). Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: Prevention supports treatment completion. BMC Urology.
Chicago Style (17th ed.) CitationBody, Jean-Jacques, Roger von Moos, Daniela Niepel, and Bertrand Tombal. "Hypocalcaemia in Patients with Prostate Cancer Treated with a Bisphosphonate or Denosumab: Prevention Supports Treatment Completion." BMC Urology Sep. 2018.
MLA (9th ed.) CitationBody, Jean-Jacques, et al. "Hypocalcaemia in Patients with Prostate Cancer Treated with a Bisphosphonate or Denosumab: Prevention Supports Treatment Completion." BMC Urology, Sep. 2018.
Warning: These citations may not always be 100% accurate.
